Selected article for: "acute respiratory syndrome and financial term"

Author: Chan, Andrew T.; Drew, David A.; Nguyen, Long H.; Joshi, Amit D.; Ma, Wenjie; Guo, Chuan-Guo; Lo, Chun-Han; Mehta, Raaj S.; Kwon, Sohee; Sikavi, Daniel R.; Magicheva-Gupta, Marina V.; Fatehi, Zahra S.; Flynn, Jacqueline J.; Leonardo, Brianna M.; Albert, Christine M.; Andreotti, Gabriella; Beane-Freeman, Laura E.; Balasubramanian, Bijal A.; Brownstein, John S.; Bruinsma, Fiona; Cowan, Annie N.; Deka, Anusila; Ernst, Michael E.; Figueiredo, Jane C.; Franks, Paul W.; Gardner, Christopher D.; Ghobrial, Irene M.; Haiman, Christopher A.; Hall, Janet E.; Deming-Halverson, Sandra L.; Kirpach, Brenda; Lacey, James V.; Marchand, Loïc Le; Marinac, Catherine R.; Martinez, Maria Elena; Milne, Roger L.; Murray, Anne M.; Nash, Denis; Palmer, Julie R.; Patel, Alpa V.; Rosenberg, Lynn; Sandler, Dale P.; Sharma, Shreela V.; Schurman, Shepherd H.; Wilkens, Lynne R.; Chavarro, Jorge E.; Eliassen, A. Heather; Hart, Jaime E.; Kang, Jae Hee; Koenen, Karestan C.; Kubzansky, Laura D.; Mucci, Lorelei A.; Ourselin, Sebastien; Rich-Edwards, Janet W.; Song, Mingyang; Stampfer, Meir J.; Steves, Claire J.; Willett, Walter C.; Wolf, Jonathan; Spector, Tim
Title: The COronavirus Pandemic Epidemiology (COPE) Consortium: A Call to Action
  • Cord-id: 5lajxlmp
  • Document date: 2020_5_5
  • ID: 5lajxlmp
    Snippet: The rapid pace of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; COVID-19) pandemic presents challenges to the real-time collection of population-scale data to inform near-term public health needs as well as future investigations. We established the COronavirus Pandemic Epidemiology (COPE) consortium to address this unprecedented crisis on behalf of the epidemiology research community. As a central component of this initiative, we have developed a COVID Symptom Study (previousl
    Document: The rapid pace of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; COVID-19) pandemic presents challenges to the real-time collection of population-scale data to inform near-term public health needs as well as future investigations. We established the COronavirus Pandemic Epidemiology (COPE) consortium to address this unprecedented crisis on behalf of the epidemiology research community. As a central component of this initiative, we have developed a COVID Symptom Study (previously known as the COVID Symptom Tracker) mobile application as a common data collection tool for epidemiologic cohort studies with active study participants. This mobile application collects information on risk factors, daily symptoms, and outcomes through a user-friendly interface that minimizes participant burden. Combined with our efforts within the general population, data collected from nearly 3 million participants in the United States and United Kingdom are being used to address critical needs in the emergency response, including identifying potential hot spots of disease and clinically actionable risk factors. The linkage of symptom data collected in the app with information and biospecimens already collected in epidemiology cohorts will position us to address key questions related to diet, lifestyle, environmental, and socioeconomic factors on susceptibility to COVID-19, clinical outcomes related to infection, and long-term physical, mental health, and financial sequalae. We call upon additional epidemiology cohorts to join this collective effort to strengthen our impact on the current health crisis and generate a new model for a collaborative and nimble research infrastructure that will lead to more rapid translation of our work for the betterment of public health.

    Search related documents:
    Co phrase search for related documents
    • academic medical center and accountability health insurance portability act: 1, 2
    • academic medical center and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • academic medical center and additional cohort: 1
    • accountability health insurance portability act and acute respiratory syndrome: 1
    • accountability health insurance portability and acute respiratory syndrome: 1
    • ace inhibitor and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and adaptable real time data capture platform: 1
    • acute respiratory syndrome and additional cohort: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute respiratory syndrome and additional evidence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and additional population: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • acute subclinical and adaptable real time data capture platform: 1